H.R. 5958
118th Congress
House
Drug-price Transparency for Consumers Act of 2023
Official title: To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
Health
Administrative law and regulatory proceduresCivil actions and liabilityDepartment of Health and Human ServicesHealth care costs and insurance
More subjectsShow fewer subjects
Marketing and advertisingPrescription drugs
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Oct 25, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 13, 2023
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
3
Cosponsors
1
Cite this page
U.S. Congress. (2026). H.R. 5958: Drug-price Transparency for Consumers Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-5958/
"H.R. 5958: Drug-price Transparency for Consumers Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-5958/.
H.R. 5958, 118th Cong. (2026), https://openamerica.io/bill/118-HR-5958/.
[H.R. 5958: Drug-price Transparency for Consumers Act of 2023](https://openamerica.io/bill/118-HR-5958/)